Dr Stephen France
Senior Business Manager
Stephen has a background in developing new product concepts based on emerging market trends. His experience spans business operations, technology licensing and investment funding in the life sciences and pharmaceutical sectors. Previous to joining UCLB Stephen was a venture manager at UMI3 Ltd where he managed a portfolio of venture backed biotechnology companies, including Galexir Healthcare, Spectromics Ltd, PharmaKure Ltd, IF Sensing Ltd, Bioxydyn Ltd, Manchester Imaging Ltd, Clin-e-cal Ltd and Renephra Ltd. He was also previously a director of Curapel Limited, a specialist dermatology business, where he supported the translation of the businesses technology pipeline from the laboratory bench, through development and into human studies. In 2017 Stephen was part of the management team that successfully completed an IPO for SkinBioTherapeutics PLC, a microbiome company focused on skin health. He has a PhD in molecular cancer biology from the University of Glasgow, carried out postdoctoral research at Harvard University (USA) and has worked in the pharmaceutical industry with AstraZeneca PLC.